- Home
- OPRA vs ZLAB Comparison
OPRA vs ZLAB Comparison
Compare OPRA & ZLAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OPRA
- ZLAB
- Stock Information
- Founded
- OPRA 1996
- ZLAB 2013
- Country
- OPRA Norway
- ZLAB Cayman Islands
- Employees
- OPRA N/A
- ZLAB N/A
- Industry
- OPRA Computer Software: Prepackaged Software
- ZLAB Biotechnology: Pharmaceutical Preparations
- Sector
- OPRA Technology
- ZLAB Health Care
- Exchange
- OPRA Nasdaq
- ZLAB Nasdaq
- Market Cap
- OPRA 1.3B
- ZLAB 3.5B
- IPO Year
- OPRA 2018
- ZLAB 2017
- Fundamental
- Price
- OPRA $15.53
- ZLAB $32.00
- Analyst Decision
- OPRA Strong Buy
- ZLAB Buy
- Analyst Count
- OPRA 5
- ZLAB 4
- Target Price
- OPRA $24.70
- ZLAB $47.37
- AVG Volume (30 Days)
- OPRA 531.3K
- ZLAB 1.7M
- Earning Date
- OPRA 04-28-2025
- ZLAB 05-08-2025
- Dividend Yield
- OPRA 5.15%
- ZLAB N/A
- EPS Growth
- OPRA N/A
- ZLAB N/A
- EPS
- OPRA 0.90
- ZLAB N/A
- Revenue
- OPRA $480,648,000.00
- ZLAB $398,988,000.00
- Revenue This Year
- OPRA $20.29
- ZLAB $45.57
- Revenue Next Year
- OPRA $15.79
- ZLAB $47.91
- P/E Ratio
- OPRA $17.26
- ZLAB N/A
- Revenue Growth
- OPRA 21.12
- ZLAB 49.59
- 52 Week Low
- OPRA $10.11
- ZLAB $15.65
- 52 Week High
- OPRA $22.50
- ZLAB $39.77
- Technical
- Relative Strength Index (RSI)
- OPRA 49.29
- ZLAB 49.83
- Support Level
- OPRA $13.61
- ZLAB $28.34
- Resistance Level
- OPRA $15.60
- ZLAB $34.59
- Average True Range (ATR)
- OPRA 0.90
- ZLAB 2.12
- MACD
- OPRA 0.18
- ZLAB 0.40
- Stochastic Oscillator
- OPRA 91.53
- ZLAB 74.98
About OPRA Opera Limited
Opera Ltd is a world-wide internet brand with a large, engaged, and growing base. It offers users products and services that include a variety of PC and mobile browsers, Opera Gaming portals and development tools, Opera News content recommendation products, and a number of e-commerce products and services. Its browser's features include tabbed browsing, data savings, PC/mobile sync, and numerous features focused on privacy and security, including ad blocking and a built-in VPN. Its browser products include Opera Mini, Opera Browser for Android and iOS, Opera for Computers, Opera GX and Opera GX Mobile, separate browsers tailored for gamers. Geographically, the company generates maximum revenue from the United States, followed by Singapore, Nigeria, Russia, and other locations.
About ZLAB Zai Lab Limited
Zai Lab Ltd is a biopharmaceutical company focusing on discovering or licensing, developing, and commercializing proprietary therapeutics that address areas of unmet medical need including in the fields of oncology, autoimmune and infectious diseases. The pipeline of proprietary drug candidates of the company includes ZL-1218 (CCR8) Solid Tumors, ZL-1310 (DLL3 ADC) ES-SCLC Other NECs, ZL-6301 (ROR1 ADC) Solid Tumors, ZL 6201 (LRRC15 ADC) Solid Tumors.